4
Changes in Ownership
Cabaletta Bio, Inc. Filed Acc 0000899243-19-026016
Options or other derivatives
- Chief Medical Officer acquired 48,836 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Chang David J. Chief Medical Officer | 2019-10-24 | Grant or award · Stock Option (Right to Buy) | +48,836 | 48,836 | D | ||
Loading xslF345X03/doc4.xml…